Catalyst Wire Dossier Catalyst Wire Dossier

Combined Measles-Mumps-Rubella (MMR) vaccine

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Combined Measles-Mumps-Rubella (MMR) vaccine, covering 2017-09-13 to 2017-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age [Phase 3]

See pricing